Baird raised the firm’s price target on CVS Health (CVS) to $94 from $92 and keeps an Outperform rating on the shares. The firm updated its model as it becomes more positive on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Midday Fly By: Health insurers get ‘positive surprise’ from CMS
- Deutsche sees margin pressure despite ‘positive surprise’ from CMS
- Video: Health insurers rise after CMS finalizes 2027 Medicare payment hike
- Morning Movers: Broadcom gains following pact to supply custom TPUs for Google
- Closing Bell Movers: Health insurers rise on higher Medicare rate hike